![Servier - Moved by you..]({"type":"image" , "src" : "/sda/112354/JournalAd-Servier-5s.gif"})
References
- Liu L, Zeng B, Zhang J, et al. Impact of subclinical hypothyroidism on in-hospital outcomes and long-term mortality among acute myocardial infarction patients with diabetic mellitus. Acta Cardiol. 2023;1–9. doi:10.1080/00015385.2023.2279421.
- Mehran L, Amouzegar A, Azizi F. Thyroid disease and the metabolic syndrome. Curr Opin Endocrinol Diabetes Obes. 2019;26(5):256–265. doi:10.1097/MED.0000000000000500.
- Boucai L, Hollowell JG, Surks MI. An approach for development of age-, gender-, and ethnicity-specific thyrotropin reference limits. Thyroid. 2011;21(1):5–11. doi:10.1089/thy.2010.0092.
- Van den Berghe G. Thyroid non-thyroidal illness in the ICU: a syndrome with different faces. Thyroid. 2014;24(10):1456–1465. doi:10.1089/thy.2014.0201.
- He X, Gao R, Wu Y, et al. Low FT3/FT4 ratio is linked to poor prognosis of acute myocardial infarction in euthyroid patients with type 2 diabetes mellitus. J Clin Med. 2022;11(21):6530. doi:10.3390/jcm11216530.
- Shi C, Bao Y, Chen X, et al. The effectiveness of thyroid hormone replacement therapy on heart failure and low-triiodothyronine syndrome: an updated systematic review and meta-analysis of randomized controlled trials. Endocr Pract. 2022;28(11):1178–1186. doi:10.1016/j.eprac.2022.07.004.
![A worldwide pioneer in biotechnology.]({"type":"image" , "src" : "/sda/112403/JournalAd-Amgen-MPU.png"})
![A bold vision to stop cardiovascular disease from being a leading cause of death.]({"type":"image" , "src" : "/sda/112402/JournalAd-amarin.jpg"})